These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21053952)

  • 1. Effects of charge on antibody tissue distribution and pharmacokinetics.
    Boswell CA; Tesar DB; Mukhyala K; Theil FP; Fielder PJ; Khawli LA
    Bioconjug Chem; 2010 Dec; 21(12):2153-63. PubMed ID: 21053952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
    Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K
    Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions.
    Vanhoye D; Bruston F; El Amri S; Ladram A; Amiche M; Nicolas P
    Biochemistry; 2004 Jul; 43(26):8391-409. PubMed ID: 15222751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics.
    Datta-Mannan A; Thangaraju A; Leung D; Tang Y; Witcher DR; Lu J; Wroblewski VJ
    MAbs; 2015; 7(3):483-93. PubMed ID: 25695748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of hydroxyapatite nanocrystals with human immunoglobulin G for nanomedical applications.
    Iafisco M; Varoni E; Di Foggia M; Pietronave S; Fini M; Roveri N; Rimondini L; Prat M
    Colloids Surf B Biointerfaces; 2012 Feb; 90():1-7. PubMed ID: 22015181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted drug delivery using immunoconjugates: principles and applications.
    Pasquetto MV; Vecchia L; Covini D; Digilio R; Scotti C
    J Immunother; 2011; 34(9):611-28. PubMed ID: 21989410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates.
    Erickson HK; Widdison WC; Mayo MF; Whiteman K; Audette C; Wilhelm SD; Singh R
    Bioconjug Chem; 2010 Jan; 21(1):84-92. PubMed ID: 19891424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cationization of monoclonal antibodies: another step towards the "magic bullet"?
    Vaisitti T; Deaglio S; Malavasi F
    J Biol Regul Homeost Agents; 2005; 19(3-4):105-12. PubMed ID: 16602624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of directly labeling antibodies with rhenium-188.
    Winnard P; Virzi E; Fogarasi M; Rusckowski M; Hnatowich DJ
    Q J Nucl Med; 1996 Jun; 40(2):151-60. PubMed ID: 8909100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy.
    Kogelberg H; Tolner B; Sharma SK; Lowdell MW; Qureshi U; Robson M; Hillyer T; Pedley RB; Vervecken W; Contreras R; Begent RH; Chester KA
    Glycobiology; 2007 Jan; 17(1):36-45. PubMed ID: 17000699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced protein steering: cooperative electrostatic and van der Waals forces in antigen-antibody complexes.
    Persson BA; Jönsson B; Lund M
    J Phys Chem B; 2009 Jul; 113(30):10459-64. PubMed ID: 19583233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two and three-dimensional pattern recognition of organized surfaces by specific antibodies.
    Addadi L; Rubin N; Scheffer L; Ziblat R
    Acc Chem Res; 2008 Feb; 41(2):254-64. PubMed ID: 18217721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies.
    Henriksen G; Bruland OS; Larsen RH
    Anticancer Res; 2005; 25(1A):9-15. PubMed ID: 15816513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
    Quadri SM; Vriesendorp HM
    Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of antibody pharmacokinetics by chemical polysialylation.
    Constantinou A; Epenetos AA; Hreczuk-Hirst D; Jain S; Deonarain MP
    Bioconjug Chem; 2008 Mar; 19(3):643-50. PubMed ID: 18307285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention.
    Graff CP; Wittrup KD
    Cancer Res; 2003 Mar; 63(6):1288-96. PubMed ID: 12649189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derlin-1 is overexpressed on the tumor cell surface and enables antibody-mediated tumor targeting therapy.
    Ran Y; Hu H; Hu D; Zhou Z; Sun Y; Yu L; Sun L; Pan J; Liu J; Liu T; Yang Z
    Clin Cancer Res; 2008 Oct; 14(20):6538-45. PubMed ID: 18927294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of therapeutic monoclonal antibodies used in oncology.
    Levêque D; Wisniewski S; Jehl F
    Anticancer Res; 2005; 25(3c):2327-43. PubMed ID: 16080460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.